National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

salinosporamide A
A naturally-occurring salinosporamide, isolated from the marine actinomycete Salinospora tropica, with potential antineoplastic activity. Salinosporamide A irreversibly binds to and inhibits the 20S catalytic core subunit of the proteasome by covalently modifying its active site threonine residues; inhibition of ubiquitin-proteasome mediated proteolysis results in an accumulation of poly-ubiquitinated proteins, which may result in the disruption of cellular processes, cell cycle arrest, the induction of apoptosis, and the inhibition of tumor growth and angiogenesis. This agent more may more potent and selective than the proteasome inhibitor bortezomib. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:salinosporin A
Code name:NPI-0052



Previous:S-adenosyl-L-methionine disulfate p-toluene-sulfonate, S-CKD602, sabarubicin, safingol, Salagen
Next:salirasib, salmonella VNP20009, Salvia officinalis extract tablet, samarium Sm 153 lexidronam pentasodium, Sandimmun

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov